glp-1 trends RA prescription trends: January 2019 – December 2025 Glucagon-Like Peptide 1 (GLP-1) Agonist
Description
Others said the drugs made it hard to keep up with responsibilities at home, at work, or in relationships
Around 25% AF/Aflutter events occurred after a TSH test but before a subsequent levothyroxine dose adjustment
Was sagt die Wissenschaft
In particular, linagliptin might be a good choice as initial therapy in a patient with chronic kidney disease at risk for hypoglycemia
Oliver, L., et al
